ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

OBJECTIVE: We report the functional status and steroid dosing changes in a phase II clinical trial of bevacizumab and temozolomide for upfront treatment of patients with GBM and age ≥70. Evaluation of steroid use and functional status changes are important aspects of determining treatment success in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Bahng, Hye Hyun, Green, Stacey, Lai, Albert, Hu, Jethro, Green, Richard, Iwamoto, Fabio, Lassman, Andrew B, Cloughesy, Timothy, Nghiemphu, Phioanh
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693034/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.074
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak